These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9821965)

  • 41. Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study.
    Zaman K; Rahim F; Taha M; Wadood A; Shah SAA; Ahmed QU; Zakaria ZA
    Sci Rep; 2019 Nov; 9(1):16015. PubMed ID: 31690793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Basic fibroblast growth factor-induced angiogenesis in the chick embryo chorioallantoic membrane: an electron microscopy study.
    Ribatti D; Nico B; Bertossi M; Roncali L; Presta M
    Microvasc Res; 1997 Mar; 53(2):187-90. PubMed ID: 9143552
    [No Abstract]   [Full Text] [Related]  

  • 43. Purification of thymidine phosphorylase from Escherichia coli and its photoinactivation in the presence of thymine, thymidine, and some halogenated analogs.
    Voytek P
    J Biol Chem; 1975 May; 250(10):3660-5. PubMed ID: 236298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of thymidine phosphorylase and uridine phosphorylase in (fluoro)pyrimidine metabolism in peripheral blood mononuclear cells.
    Temmink OH; de Bruin M; Laan AC; Turksma AW; Cricca S; Masterson AJ; Noordhuis P; Peters GJ
    Int J Biochem Cell Biol; 2006; 38(10):1759-65. PubMed ID: 16798057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of thymidine phosphorylase (PD-ECGF) from SD-lymphoma by phosphonomethoxyalkyl thymines.
    Votruba I; Pomeisl K; Tloust'ová E; Holý A; Otová B
    Biochem Pharmacol; 2005 May; 69(10):1517-21. PubMed ID: 15857616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities.
    Bera H; Tan BJ; Sun L; Dolzhenko AV; Chui WK; Chiu GN
    Eur J Med Chem; 2013 Sep; 67():325-34. PubMed ID: 23871912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
    Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase.
    Taha M; Rashid U; Imran S; Ali M
    Bioorg Med Chem; 2018 Jul; 26(12):3654-3663. PubMed ID: 29853339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of anti-angiogenic tyrosine kinase inhibition on wound healing--the obvious and not so obvious.
    McCarty ME; Ellis LM
    Cancer Biol Ther; 2002; 1(2):127-9. PubMed ID: 12212612
    [No Abstract]   [Full Text] [Related]  

  • 50. QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interaction.
    Mekapati SB; Hansch C
    Bioorg Med Chem; 2001 Dec; 9(12):3225-30. PubMed ID: 11711298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poly-L-lysine/heparin stimulates angiogenesis in chick embryo chorioallantoic membrane.
    Pacini S; Gulisano M; Vannucchi S; Ruggiero M
    Biochem Biophys Res Commun; 2002 Jan; 290(2):820-3. PubMed ID: 11785975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.
    Oikawa T; Sasaki M; Inose M; Shimamura M; Kuboki H; Hirano S; Kumagai H; Ishizuka M; Takeuchi T
    Anticancer Res; 1997; 17(3C):1881-6. PubMed ID: 9216639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
    Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-angiogenic drug AGM1470 suppresses smooth muscle cell migration induced by endothelial PDGF.
    Shigematsu K; Yasuhara H; Shigematsu H; Muto T
    Eur J Vasc Endovasc Surg; 1997 Oct; 14(4):290-8. PubMed ID: 9366793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470.
    Klauber N; Rohan RM; Flynn E; D'Amato RJ
    Nat Med; 1997 Apr; 3(4):443-6. PubMed ID: 9095179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thymidine phosphorylase as a target for imaging and therapy with thymine analogs.
    Klecker RW; Collins JM
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):407-12. PubMed ID: 11761459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
    Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
    Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II.
    Bera H; Ojha Pk; Tan BJ; Sun L; Dolzhenko AV; Chui WK; Chiu GN
    Eur J Med Chem; 2014 May; 78():294-303. PubMed ID: 24686016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Syntheses of pyrimidine acyclic nucleoside phosphonates as potent inhibitors of thymidine phosphorylase (PD-ECGF) from SD-lymphoma.
    Pomeisl K; Votruba I; Holý A; Pohl R
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1025-8. PubMed ID: 18058530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, anti-thymidine phosphorylase activity and molecular docking of 5-thioxo-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ones.
    Bera H; Lee MH; Sun L; Dolzhenko AV; Chui WK
    Bioorg Chem; 2013 Oct; 50():34-40. PubMed ID: 23968897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.